Literature DB >> 17494121

Re: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

Paul C M S Verhagen1.   

Abstract

Entities:  

Year:  2007        PMID： 17494121     DOI： 10.1016/j.eururo.2007.02.022

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma.

Authors:  Tangliang Zhao; Yi Bao; Xinxin Gan; Jie Wang; Qiong Chen; Zhihui Dai; Bing Liu; Anbang Wang; Shuhan Sun; Fu Yang; Linhui Wang
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

2.  Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma.

Authors:  Qinke Li; Wenbo Yang; Maoqing Lu; Ronggui Zhang
Journal:  Med Sci Monit       Date:  2020-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.